MiniMed Group, Inc. (NASDAQ: MMED) is a Healthcare company (Medical - Equipment & Services) with a market capitalization of $5.0B. The Maz Rating grades it against the other companies in its sector.
MiniMed Group, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $17.78, MiniMed Group, Inc. trades at 1.6x sales and 1.4x book value, with an EV/EBITDA of 28.7. Over the last twelve months it generated about $3.2B of revenue and a net loss of $335M. It runs a gross margin of 53.8%, an operating margin of 0.5% and a net margin of -10.2%. It shows return on equity of -9.1%, return on invested capital of 0.4% and a free cash flow yield of -6.3%. On the balance sheet: a debt-to-equity ratio of 0.02 and a current ratio of 1.81. Over the past 52 weeks the share price ranged from $10.65 to $24.43, with a beta of -3.71.
MiniMed Group, Inc. does not currently pay a dividend.
8 Wall Street analyst ratings cover the stock: 8 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.